PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

36,672 stories, page 173 of 612

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07154927: Evaluation of Feasibility of Ultrasonography Guided Pulmonary Artery Catheterization in Pulmonary Hypertension Diagnosis

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07141524: Optimizing Breathing and Blood Flow in Patients Treated With VA ECMO

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07109817: Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07081061: Clinical Outcomes of a Digital Mental Health Intervention for Moderate/Severe Depression and Anxiety

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06976268: A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06960798: Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06926660: A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06895863: COpenhagen Magnetic Personalized Accelerated Brain Circuit Therapy for Treatment Resistant Depression

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06834932: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06767124: Veech Ketone Ester to Support Brain Energy in Mild Cognitive Impairment and Early Alzheimer's Disease

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06365658: Cognitive Functioning in Adults With Somatic Diseases and General Population From a Biopsychosocial Perspective

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06300320: A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06192758: Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06151964: A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06123988: Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06112847: Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05986318: Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05705414: Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05618574: Nitrite Supplementation in Long COVID Patients

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05367440: Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05306600: Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05238740: Comparison of Radiographic Fusion Rate and Clinical Outcome of ALIF and XLIF Performed With Either Recombinant Human Bone Morphogenetic Protein-2 or ViviGen®

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05230459: A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05044819: Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04663308: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03961243: Lentiviral FIX Gene Therapy

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03914768: Immune Modulatory DC Vaccine Against Brain Tumor

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03644186: To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03614650: Immunotherapy Treating GI Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03356808: Antigen-specific T Cells Against Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03356782: Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03204123: PSMA PET Imaging of Recurrent Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01959698: Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Europe Bioconjugation Market Size, Share,Trends, Growth Analysis Report, 2029

MarketsandMarketsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump’s FDA nominee could renew scrutiny to abortion drug risk: pro-life org CEO

New York PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

North America Al in Clinical Trials Market (2024-2029)

MarketsandMarketsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hanmi Signs $2.3B Obesity Drug Deal With Roche[K-Bio Pulse]

edaily.co.krOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Here’s How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years

BenzingaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What Cannabis Manufacturers Can Learn from the Pharmaceutical Industry About Trace Metal Impurities in Plastic Materials

Cannabis Industry JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Edesa Biotech (NASDAQ: EDSA) major holder's multi-million-share stake detailed

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Enwei Pharmaceutical Co., Ltd. Class A – SZSE:301331

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

XBI Forecast: $174.79 Tests Biotech ETF Breakout Strength

FXEmpireOriginal source
🌍discoverynews.google.comTier 2 · Trade media

New Jazz cancer drug approval could drive blockbuster sales

BioPharma DiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Health Care Up as Biotech Momentum Persists -- Health Care Roundup

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PDA becomes latest pharmacy body to publish AI guidance

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors

MarketWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[New York Stock Market Highlights] Pharmaceutical stocks bought, AMD rises; sporting goods retailers plunge (25th)

MoomooOriginal source
🌍Industryallogene.comTier 1 · Company source

4: Statement of changes in beneficial ownership of securities

Allogene TherapeuticsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

La. challenge to mail-order abortion pills headed back to court

American PressOriginal source
🇺🇸universitynews.mit.eduTier 2 · Direct publisher

Cells use a little-known molecule to protect themselves from iron overload

MIT Biology NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Pharmaceutical Grants Inducement Restricted Stock Units to 23 New Employees

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Velan Capital lifts Edesa Biotech (EDSA) stake to 9.99% with warrant leverage

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Will Legend Biotech’s (LEGN) Move to Q2 Profitability Reshape Its Investment Narrative?

simplywall.stOriginal source
🇨🇦Researchnews.ubc.caTier 2 · Direct publisher

Lunchbox labour is back — here’s how Canada’s new school food program can grow

University of British ColumbiaOriginal source
🌍discoverynews.google.comTier 2 · Trade media

BMS Texas investment advances pharma’s modular manufacturing agenda

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Walter V. Klemp Discloses Investment at Moleculin Biotech with 9.87% Stake

TradingViewOriginal source
🌍Industryadial.comTier 1 · Company source

Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Adial PharmaceuticalsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tracking ripubatide across three clinical registries

ClarivateOriginal source
🇺🇸Industrybiomarin.comTier 1 · Company source

Bringing Science Full Circle: Ben Schooler Shares What Has Motivated His Path at BioMarin

BioMarin PharmaceuticalOriginal source
🌍Industrynews.intermountainhealth.orgTier 3 · Secondary coverage

Transplant Patients, Physicians, and Caregivers from Four Hospitals Celebrate UTAH Cardiac Transplant Program’s 40th Anniversary – A National Model of Collaboration

<![CDATA[Intermountain Health Newsroom]]>Original source